Pulnovo Medical
Private
Medical device company developing pulmonary artery denervation technology for the treatment of pulmonary hypertension and related cardiovascular conditions.
Company Info
Sector:Medical Devices
Headquarters:Shanghai, China
Founded:2016
Upcoming Milestones & Key Dates
2026-08
Clinical
First two U.S. patients enrolled in PULSE-LHD IDE trial
Clinical Development Pipeline
Pulnovo Denervation System
Target: Pulmonary artery nervesRecent News
No recent news updates available for this company.